Xcout Intel
IMAGINAB, INC. competitors & alternatives
The 12 closest competitors and alternatives to IMAGINAB, INC. among biotechnology companies — ranked by similarity to what IMAGINAB, INC. actually does, not by market-cap band.
Subscribe to see IMAGINAB, INC.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About IMAGINAB, INC.
ImaginAb, Inc. is a global biotechnology company headquartered in California, with operations in Los Angeles and San Diego. It focuses on developing next-generation imaging and radiopharmaceutical products for cancer immunology.
IMAGINAB, INC. at a glance
IMAGINAB, INC. is a biotechnology company headquartered in United States. It has raised at least $26.3M across the 3 funding rounds on record. Its most recent funding round, Growth, raised $13M in June 2021. Xcout tracks 8 named people at IMAGINAB, INC., including David Fractor (Chief Financial Officer).
IMAGINAB, INC. leadership
- David FractorChief Financial Officer
- Anna M. WuFounder and Chief Scientific Advisor
- Jill DurkinVP, Financial Strategy and Planning
- Kristin SchmiedehausenVP, Medical Affairs
- Kathleen BradyAssociate Director, Quality Assurance
- Friedhelm BlobelIndependent Non-Executive Director
2 more named people on record for IMAGINAB, INC., with roles, board committees and tenure — see the full roster →
IMAGINAB, INC. funding rounds
At least $26.3M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Growth | $13M | 6 named | |
| — | $8M | 1 named | |
| SEC Form D filing | $5.3M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 IMAGINAB, INC. competitors
Ranked by semantic similarity — how close each company is to IMAGINAB, INC. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Diagnostics
ABSCINT is a clinical-stage biotechnology company that develops platform production processes for rapid creation of cold kits for molecular imaging in oncology and immunology. Headquartered in Belgium, the privately held firm focuses on innovative diagnostic and therapeutic applications using single-domain antibodies.
Similar biotechnology company
On Target Laboratories, Inc. is a biotechnology company founded in 2010 and headquartered in West Lafayette, Indiana. It discovers and develops targeted intraoperative molecular imaging agents to illuminate cancer during surgery.
Health Care
Spago Nanomedical is a clinical-stage pharmaceutical company that develops precision nanomedicine products for the diagnosis and treatment of cancer and other severe diseases. Its pipeline includes Tumorad, a targeted radionuclide therapy for various cancers, and SpagoPix, a polymeric contrast agent designed to improve the precision of MRI diagnostics.
Biotech
ImmunityBio, Inc. is a public clinical-stage immunotherapy company headquartered in San Diego, California. As a member of the NantWorks ecosystem, it focuses on developing next-generation cancer vaccines and immunotherapies.
Similar biotechnology company
Inmagene Biopharmaceuticals is a clinical-stage biotechnology company headquartered in San Diego, California. The firm is dedicated to the research, development, and advancement of novel therapeutic medicines. It operates within the life sciences sector, focusing on clinical development and corporate mergers.
Similar biotechnology company
Theragene Pharmaceuticals, Inc. is a privately held biopharmaceutical company headquartered in Los Angeles, California, focusing on immunotherapy technologies.
Biotech
ImageneBio Inc (IMA) is a biotechnology company with therapies currently undergoing human trials. The firm concentrates on creating innovative medical treatments for a variety of immune-related and inflammatory diseases. A key component of their pipeline is IMG-007, a non-depleting anti-OX40 monoclonal antibody, which is now in Phase 2b clinical studies targeting atopic dermatitis.
Biotech
ImmPACT Bio USA, Inc. is a clinical-stage biotechnology company headquartered in West Hills, California. The company focuses on developing advanced cell therapies and immunotherapies to treat cancer and other serious diseases.
Similar biotechnology company
IMBiologics Corp. is a biotechnology company headquartered in Suwon-si, Gyeonggi-do, South Korea. The firm focuses on drug discovery, development of biotherapeutic pipelines, and clinical trials for innovative antibody treatments.
Similar biotechnology company
ImmunoPhotonics, Inc. is a privately owned clinical-stage biopharmaceutical and pharmaceutical manufacturing company located in St. Louis, Missouri, specializing in interventional immuno-oncology.
Similar biotechnology company
IconOVir Bio, Inc. is a preclinical-stage biotechnology company headquartered in New York, United States, with a primary location in San Diego, California. Established in 2020, the venture-backed company is dedicated to pioneering novel oncolytic viral therapies to cure cancer and restore life to patients.
Similar biotechnology company
CytoImmune Therapeutics is a clinical-stage biotechnology company headquartered in Duarte, California, focused on developing novel cell therapies for cancer treatment.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of IMAGINAB, INC. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for IMAGINAB, INC.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →